Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany.

Abstract

OBJECTIVE Super-refractory status epilepticus (SRSE) is a severe condition in which a patient in status epilepticus (SE) for ≥24 h does not respond to first-, second-, or third-line therapy. The economic impact of SRSE treatment remains unclear. A health insurance research database was used for a population-based estimation of SRSE-associated inpatient… (More)
DOI: 10.1111/epi.13837

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics